Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-118,744
Closed -$537K 3903
2025
Q4
$537K Buy
+118,744
New +$608K ﹤0.01% 3202
2025
Q1
Sell
-440,509
Closed -$1.5M 2131
2024
Q4
$1.5M Sell
440,509
-339,496
-44% -$979K ﹤0.01% 1345
2024
Q3
$2.29M Sell
780,005
-1,642,723
-68% -$5.41M 0.01% 1146
2024
Q2
$8.24M Buy
+2,422,728
New +$7.92M 0.02% 681
2023
Q2
Sell
-88,846
Closed -$619K 2273
2023
Q1
$619K Buy
+88,846
New +$775K ﹤0.01% 1192

Steven Cohen's CVAC Position: Q1 2026 in Review

Steven Cohen sold out of CureVac (CVAC) in Q1 2026, closing a stake of 118,744 shares — an estimated $537K sold.

Steven Cohen first reported a position in CVAC in Q1 2023 and held it in 5 quarters. The position peaked at $8.24M in Q2 2024. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Steven Cohen reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Steven Cohen sold 118,744 CureVac shares in Q1 2026, an estimated $537K.
  • Steven Cohen first reported a position in CureVac in Q1 2023 and held it in 5 quarters.
  • Steven Cohen's CureVac position peaked at $8.24M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.